Back to 
CAPSTONE INVESTMENT ADVISORS, LLC
CAPSTONE INVESTMENT ADVISORS, LLC
ASND
Showing 0 of 3 quarters
Position history for CAPSTONE INVESTMENT ADVISORS, LLC's holdings in <![CDATA[ASCENDIS PHARMA A/S]]>
No. Capstone Investment Advisors exited its ASND (<![cdata[ascendis Pharma A/S]]>) position in Q1 2024. Its Q4 2023 13F listed 3,681 shares worth $463,622. Capstone Investment Advisors first reported ASND in Q3 2023 and held it in 2 quarterly 13F filings.
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
0
No position history available for this security.